BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 35602649)

  • 1. A data-driven model of brain volume changes in progressive supranuclear palsy.
    Scotton WJ; Bocchetta M; Todd E; Cash DM; Oxtoby N; VandeVrede L; Heuer H; ; Alexander DC; Rowe JB; Morris HR; Boxer A; Rohrer JD; Wijeratne PA
    Brain Commun; 2022; 4(3):fcac098. PubMed ID: 35602649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncovering spatiotemporal patterns of atrophy in progressive supranuclear palsy using unsupervised machine learning.
    Scotton WJ; Shand C; Todd E; Bocchetta M; Cash DM; VandeVrede L; Heuer H; ; Young AL; Oxtoby N; Alexander DC; Rowe JB; Morris HR; Boxer AL; Rohrer JD; Wijeratne PA
    Brain Commun; 2023; 5(2):fcad048. PubMed ID: 36938523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staging of progressive supranuclear palsy-Richardson syndrome using MRI brain charts for the human lifespan.
    Planche V; Mansencal B; Manjon JV; Meissner WG; Tourdias T; Coupé P
    Brain Commun; 2024; 6(2):fcae055. PubMed ID: 38444913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Fully Automated, Atlas-Based Approach for Superior Cerebellar Peduncle Evaluation in Progressive Supranuclear Palsy Phenotypes.
    Nicoletti G; Caligiuri ME; Cherubini A; Morelli M; Novellino F; Arabia G; Salsone M; Quattrone A
    AJNR Am J Neuroradiol; 2017 Mar; 38(3):523-530. PubMed ID: 28034996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advancing functional dysconnectivity and atrophy in progressive supranuclear palsy.
    Brown JA; Hua AY; Trujllo A; Attygalle S; Binney RJ; Spina S; Lee SE; Kramer JH; Miller BL; Rosen HJ; Boxer AL; Seeley WW
    Neuroimage Clin; 2017; 16():564-574. PubMed ID: 28951832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of two Progressive Supranuclear Palsy phenotypes with comparable initial disability.
    Shoeibi A; Litvan I; Tolosa E; Ser TD; Lee E;
    Parkinsonism Relat Disord; 2019 Sep; 66():87-93. PubMed ID: 31307919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical progression of progressive supranuclear palsy: impact of trials bias and phenotype variants.
    Street D; Malpetti M; Rittman T; Ghosh BCP; Murley AG; Coyle-Gilchrist I; Passamonti L; Rowe JB
    Brain Commun; 2021; 3(3):fcab206. PubMed ID: 34541533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates of brain atrophy and clinical decline over 6 and 12-month intervals in PSP: determining sample size for treatment trials.
    Whitwell JL; Xu J; Mandrekar JN; Gunter JL; Jack CR; Josephs KA
    Parkinsonism Relat Disord; 2012 Mar; 18(3):252-6. PubMed ID: 22079523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling trajectories of regional volume loss in progressive supranuclear palsy.
    Josephs KA; Xia R; Mandrekar J; Gunter JL; Senjem ML; Jack CR; Whitwell JL
    Mov Disord; 2013 Jul; 28(8):1117-24. PubMed ID: 23568852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Free-water imaging in Parkinson's disease and atypical parkinsonism.
    Planetta PJ; Ofori E; Pasternak O; Burciu RG; Shukla P; DeSimone JC; Okun MS; McFarland NR; Vaillancourt DE
    Brain; 2016 Feb; 139(Pt 2):495-508. PubMed ID: 26705348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and validation of the automated imaging differentiation in parkinsonism (AID-P): a multicentre machine learning study.
    Archer DB; Bricker JT; Chu WT; Burciu RG; McCracken JL; Lai S; Coombes SA; Fang R; Barmpoutis A; Corcos DM; Kurani AS; Mitchell T; Black ML; Herschel E; Simuni T; Parrish TB; Comella C; Xie T; Seppi K; Bohnen NI; Müller ML; Albin RL; Krismer F; Du G; Lewis MM; Huang X; Li H; Pasternak O; McFarland NR; Okun MS; Vaillancourt DE
    Lancet Digit Health; 2019 Sep; 1(5):e222-e231. PubMed ID: 33323270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging measures predict progression in progressive supranuclear palsy.
    Whitwell JL; Xu J; Mandrekar J; Gunter JL; Jack CR; Josephs KA
    Mov Disord; 2012 Dec; 27(14):1801-4. PubMed ID: 22415715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathological features of corticobasal degeneration presenting as corticobasal syndrome or Richardson syndrome.
    Kouri N; Murray ME; Hassan A; Rademakers R; Uitti RJ; Boeve BF; Graff-Radford NR; Wszolek ZK; Litvan I; Josephs KA; Dickson DW
    Brain; 2011 Nov; 134(Pt 11):3264-75. PubMed ID: 21933807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and cognitive correlations of regional gray matter atrophy in progressive supranuclear palsy.
    Giordano A; Tessitore A; Corbo D; Cirillo G; de Micco R; Russo A; Liguori S; Cirillo M; Esposito F; Tedeschi G
    Parkinsonism Relat Disord; 2013 Jun; 19(6):590-4. PubMed ID: 23477861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebellar contributions to cognition in corticobasal syndrome and progressive supranuclear palsy.
    Tse NY; Chen Y; Irish M; Cordato NJ; Landin-Romero R; Hodges JR; Piguet O; Ahmed RM
    Brain Commun; 2020; 2(2):fcaa194. PubMed ID: 33381758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic Resonance Imaging Measures to Track Atrophy Progression in Progressive Supranuclear Palsy in Clinical Trials.
    Quattrone A; Franzmeier N; Huppertz HJ; Klietz M; Roemer SN; Boxer AL; Levin J; Höglinger GU;
    Mov Disord; 2024 Jun; ():. PubMed ID: 38825840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.
    Brown RG; Lacomblez L; Landwehrmeyer BG; Bak T; Uttner I; Dubois B; Agid Y; Ludolph A; Bensimon G; Payan C; Leigh NP;
    Brain; 2010 Aug; 133(Pt 8):2382-93. PubMed ID: 20576697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathological correlates of structural and functional imaging biomarkers in 4-repeat tauopathies.
    Spina S; Brown JA; Deng J; Gardner RC; Nana AL; Hwang JL; Gaus SE; Huang EJ; Kramer JH; Rosen HJ; Kornak J; Neuhaus J; Miller BL; Grinberg LT; Boxer AL; Seeley WW
    Brain; 2019 Jul; 142(7):2068-2081. PubMed ID: 31081015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Diffusion Tensor Imaging and Apparent Transverse Relaxation Rate Differentiate Parkinson Disease and Atypical Parkinsonism.
    Du G; Lewis MM; Kanekar S; Sterling NW; He L; Kong L; Li R; Huang X
    AJNR Am J Neuroradiol; 2017 May; 38(5):966-972. PubMed ID: 28364007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical correlates of longitudinal brain atrophy in progressive supranuclear palsy.
    Tsai RM; Lobach I; Bang J; Whitwell JL; Senjem ML; Jack CR; Rosen H; Miller B; Boxer AL;
    Parkinsonism Relat Disord; 2016 Jul; 28():29-35. PubMed ID: 27132501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.